SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Noven Pharmaceuticals (NOVN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John McCarthy who wrote (39)3/9/1999 7:39:00 PM
From: zizzerzazzer   of 66
 
I was lucky and did not get into NOVN until only recently. It appears they have had a rocky history to say the least.

On Feb 24th, Fahnestock issued a Research Bulletin on NOVN in which they reiterated a Strong Buy. In this Bulletin they reported that
"Combipatch scripts have more than doubled from 2,025 per week in early December 1998 to 4,500 in mid-February 1999."

Good luck,
Zizz
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News